Multidisciplinary Follow-up of Patients Treated for Malignant Hematological Disease
Multidisciplinary Follow-up of Patients Treated for Malignant Hematological Disease; Focus on the Patient's Preferences and Life Situation
Studieöversikt
Status
Betingelser
Studietyp
Inskrivning (Förväntat)
Kontakter och platser
Studieorter
-
-
-
Aalborg, Danmark, 9000
- Rekrytering
- Aalborg University Hospital, Department of Hematology
-
Kontakt:
- Mia Sommer, MHSc
- Telefonnummer: +45 9766 0896
- E-post: m.sommer@rn.dk
-
Kontakt:
- Lise T Elkjær
- Telefonnummer: +45 9766 3871
- E-post: lit@rn.dk
-
Huvudutredare:
- Mia Sommer, MHSc
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- patients diagnosed with malignant hematological disease; Morbus Hodgkin and B- and T-cell disease
- patients followed before or after 1. line treatment
- patients in stable phase > 6 months after 1. line treatment
- the patients participation in the study must be assessed and decided by the doctor responsible for the patient's course of treatment
Exclusion Criteria:
- Health conditions which demands close medical monitoring
- conditions which compromise the ability to understand the study and submit informed consent (ex.: dementia and severe mental illness / disability)
- lack of capability to fill out electronic questionnaires
- poor self-care and/or compliance
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: Endast fall
- Tidsperspektiv: Blivande
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Health-Related Quality of Life (HRQoL) - General
Tidsram: HRQoL is assessed every 2, 3, 4 or 6 months, up to 18 months.
|
Patients will be asked to electronically fill out questionnaires before each consultation. The questionnaire that will be used to measure HRQoL is SF-36. SF-36 is a generic questionnaire which can be used to assess HRQoL in the general public. |
HRQoL is assessed every 2, 3, 4 or 6 months, up to 18 months.
|
|
Health-Related Quality of Life (HRQoL) - Disease specific
Tidsram: HRQoL is assessed every 2, 3, 4 or 6 months, up to 18 months.
|
Patients will be asked to electronically fill out questionnaires before each consultation. The questionnaire that will be used to measure HRQoL is EORTC C30 QLQ. EORTC C30 QLQ is a disease specific questionnaire which can be used to assess HRQoL in patients diagnosed with cancer |
HRQoL is assessed every 2, 3, 4 or 6 months, up to 18 months.
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Symptoms of depression and anxiety
Tidsram: Symptoms of depression and anxiety will be assessed every 2, 3, 4 or 6 month, up to 18 months
|
Data on symptoms of depression and anxiety will be collected before and after each consultation using an international validated questionnaire. The questionnaire which will be used is: Hospital Depression and Anxiety Scale (HADS) |
Symptoms of depression and anxiety will be assessed every 2, 3, 4 or 6 month, up to 18 months
|
|
Symptoms of hematological disease
Tidsram: Symptoms of disease will be assessed every 2, 3, 4 or 6 month, up to 18 months
|
Data on symptoms of disease will be collected before each consultation using an international validated questionnaire. The questionnaire which will be used is: Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF) |
Symptoms of disease will be assessed every 2, 3, 4 or 6 month, up to 18 months
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Mia Sommer, MHSc, Aalborg University Hospital
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- TVO
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .